The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?-Reference-Cited by-同舟云学术

The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?

Published:2016-02-09 Issue:2 Volume:13 Page:e1001955
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Sarpatwari Ameet,Kesselheim Aaron S.

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference24 articles.

1. Pew Charitable Trusts (2013). Persuading the prescribers: pharmaceutical industry marketing and its influence on physicians and patients. http://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2013/11/11/persuading-the-prescribers-pharmaceutical-industry-marketing-and-its-influence-on-physicians-and-patients. Accessed 26 August 2015.

2. 15 U.S.C. § 1052(e)(5).

3. Traffix Devices, Inc. v. Marketing Displays, Inc., 532 U.S. 23 (2001).

4. CTMR, 2009 O.J. (L78) 1, Art. 7.

5. Variations in pill appearance of antiepileptic drugs and the risk of nonadherence;AS Kesselheim;JAMA Intern Med,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Balancing Innovation and Access;Advances in Electronic Government, Digital Divide, and Regional Development;2024-08-30

2. Factors Associated With Prescriptions for Branded Medications in the Medicare Part D Program;JAMA Network Open;2021-03-02

3. The micro-to-macro realities of antidepressant taking: Users’ experiences in the context of contested science and industry promotion;Qualitative Social Work;2019-08-06

4. A Survey of Patients’ Perceptions of Pill Appearance and Responses to Changes in Appearance for Four Chronic Disease Medications;Journal of General Internal Medicine;2019-01-10

5. The US Biosimilar Market: Stunted Growth and Possible Reforms;Clinical Pharmacology & Therapeutics;2018-12-28